The Latest Cardiac and Vascular News
VANCOUVER, July 25, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for Brinavess™ (vernakalant hydrochloride, IV), an antiarrhythmic drug for the rapid conversion […]
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced the appointment of Michael Favet as Chief Executive Officer. Frank Fischer, after 20 years serving as CEO, continues with NeuroPace as Chairman of the Board of Directors. Mr. Favet has served on the NeuroPace board since 2016, […]
DENVER–(BUSINESS WIRE)–HeartHero announces the closing of its oversubscribed Series A funding round. This funding secures a pathway for Elliot, an industry disruptive Automated External Defibrillator (AED), to be submitted for FDA Class III approval and CE mark. This round provides resources for high-volume manufacturing and launches HeartHero’s unique go-to-market strategy for […]
Westport, CT, July 24, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform designed to address an unmet need for the electrophysiology (EP) marketplace, today announced that Ms. Julie Stephenson, BSN, MBA joined the Company as Senior Director of Clinical Affairs. […]
MARLBOROUGH, Mass., July 24, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.631 billion during the second quarter of 2019. This represents growth of 5.6 percent on a reported basis, 8.0 percent on an operational1 basis and 6.3 percent on an organic2 basis, all compared to the prior year period. The company reported […]
MENLO PARK, Calif., July 23, 2019 /PRNewswire/ — Ablacon Inc. announced today that it has entered into a $10 millionventure debt facility with Western Technology Investment (WTI). The debt is accompanied by a $2 million equity investment in the Company. This financing will help fund Ablacon’s first multicenter randomized clinical trial for Ablamap, an advanced mapping […]
IRVINE, Calif., July 23, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2019. Second Quarter and Recent Highlights Sales grew 15% to $1.1 billion; underlying1 sales grew 14% TAVR sales grew 16%; underlying […]
BRAMPTON, Ontario, July 23, 2019 (GLOBE NEWSWIRE) — Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE:MDT) — one of the world’s largest medical technology, services, and solutions company — announced today that it has been certified as a Great Place to WorkTM and has also made the list of 2019 Best […]
Philips delivers Q2 sales of EUR 4.7 billion, with 6% comparable sales growth and 8% comparable order intake growth; income from continuing operations increases to EUR 260 million and Adjusted EBITA margin improves to 11.8% Second-quarter highlights Sales in the quarter amounted to EUR 4.7 billion, with 6% comparable sales […]
BEDMINSTER, N.J. and DUBLIN, Ireland, July 17, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that it has commenced an underwritten public offering of $400,000,000 of its American Depositary Shares pursuant to a shelf registration. All of the shares in the proposed offering are to be sold […]
